These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2294393)

  • 1. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
    Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Cornelison TL; Baker TR; Piver MS; Driscoll DL
    Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal therapy of gynecologic cancers.
    Durant JR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein producing endometrial adenocarcinoma: report of a case.
    Matsukuma K; Tsukamoto N
    Gynecol Oncol; 1988 Mar; 29(3):370-7. PubMed ID: 2450056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of carcinoma corporis by intra-arterial hypertension chemotherapy].
    Yoshino N; Iwanari O; Ryukou K; Moriyama M; Kitao M; Fujita Y; Yashi K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3003-6. PubMed ID: 2782904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate.
    Deppe G; Jacobs AJ; Bruckner H; Cohen CJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):313-6. PubMed ID: 7246635
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
    Nathanson L; Meelu MA; Losada R
    Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
    Spencer DM; Bigler LR; Wilkin JK; Gams RA
    J Dermatol Surg Oncol; 1994 Aug; 20(8):544-7. PubMed ID: 8056889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
    Piver MS; Recio FO; Baker TR; Driscoll D
    Cancer; 1994 Mar; 73(6):1693-8. PubMed ID: 7512437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [UFT/CDDP treatment in advanced gastric cancer--case report].
    Suga S; Nagai H; Horiuchi Y; Ohkita T; Ibayashi J; Koyama Y
    Gan No Rinsho; 1989 Jan; 35(1):87-92. PubMed ID: 2493527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol melanoma study.
    Nathanson L; Garrison M
    World J Surg; 1995; 19(3):337-42. PubMed ID: 7638983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of advanced endometrial carcinoma with pleural effusion due to cancer by cisplatin, doxorubicin, and medroxyprogesterone acetate].
    Hayashi Y; Hachisuga M; Tateyama H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1173-6. PubMed ID: 3611885
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
    Tatman JL; Freedman RS; Scott W; Atkinson EN
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.